- The US National Highway Traffic Safety Administration launches an investigation into suspension failures affecting 1.2 million Tesla (TSLA.US) vehicles.
- SAIA INC <SAIA.O>: STIFEL RAISES TO BUY FROM HOLD; CUTS TARGET PRICE TO $438 FROM $450
- Deutsche Bank: Raises Amazon (AMZN.US) target price from $315 to $325.
- Canadian Dollar: Balanced growth supports CAD – TD Securities
- Phillips 66 Announces Additional Share Repurchase Authorization >PSX
- DEXCOM INC <DXCM.O>: STIFEL RAISES TARGET PRICE TO $95 FROM $90
- BUILDERS FIRSTSOURCE INC <BLDR.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $90 FROM $115
- BRISTOL-MYERS SQUIBB CO <BMY.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $70 FROM $65
- Électricité de Strasbourg H1 FY26 net profit drops 32.9% to EUR 56.5 million; revenue falls 7.2% to EUR 628.3 million
- CAMDEN PROPERTY TRUST <CPT.N>: STIFEL RAISES TARGET PRICE TO $123.25 FROM $118.75
- Faraday Copper announces special shareholder meeting on BHP San Manuel acquisition
- Ama Q2 revenue falls 21% to EUR 354,000
- Quirin Privatbank reiterates Buy on Villeroy & Boch, sets EUR 30.5 target
- Accor announces interim financial report for period ended June 30, 2026 is filed with AMF
- ARTHUR J. GALLAGHER & CO. : TRUIST SECURITIES RAISES TARGET PRICE TO $265 FROM $225
- T. Rowe Price schedules Q2 earnings release and conference call
- CACTUS INC <WHD.N>: STIFEL RAISES TARGET PRICE TO $72 FROM $68
- AMAZON : TRUIST SECURITIES RAISES TARGET PRICE TO $350 FROM $320
- CH ROBINSON WORLDWIDE INC <CHRW.O>: STIFEL RAISES TARGET PRICE TO $225 FROM $215
- BAXTER <BAX.N>: STIFEL RAISES TARGET PRICE TO $28 FROM $24
- Strategy Ends Its ‘Buy Every Dip’ Bitcoin Strategy, Here’s What’s Replacing It
- Coldcard Warns Mk3 Users After $38M Bitcoin Sweep Raises Security Concerns
- Atlantic Sapphire restructuring triggers mandatory takeover offer deemed fair by Pareto Securities
- AGIOS PHARMACEUTICALS INC : TRUIST SECURITIES CUTS TARGET PRICE TO $39 FROM $41
- TREASURIES-Longer-dated US yields on track for monthly gains
- T. Rowe Price Q2 FY26 EPS rises 28.6% to $2.88; net revenues increase 10.7% to $1.91 billion
- ALNYLAM PHARMACEUTICALS INC : STIFEL CUTS TARGET PRICE TO $318 FROM $444
- AGCO CORP : TRUIST SECURITIES CUTS TARGET PRICE TO $135 FROM $159
- A O SMITH CORP : STIFEL CUTS TARGET PRICE TO $70 FROM $76
- Bank of Japan Holds Rates but Signals a Hawkish Stance! Kazuo Ueda Hints at Accelerated Rate Hike Discussions at Next Meeting
- Spot platinum has just broken through the $1,630.00/oz mark, now trading at $1,629.91/oz, down 1.65% on the day; Nymex platinum futures main contract is now trading at $1,640.0/oz, down 1.22% on the day.
- Reuters survey: The average price of Brent crude oil in 2026 is expected to be $85.22 per barrel, compared to the June forecast of $84.50.
- Nordic power quarterly contracts see significant monthly gains, with low reservoir levels supporting higher prices
- Moderna (MRNA.US) falls 5.7% in pre-market trading as Q2 revenue slightly misses expectations.
- Spot silver fell 2.02% intraday to $57.77 per ounce; the main COMEX silver futures contract last traded at $58.03 per ounce, down 1.66% on the day.
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Comer Industries FY26 H1 net profit rises 44.1% to EUR 45 million; revenue increases 51.2% to EUR 676.3 million
- STRIDE INC <LRN.N>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- Siltronic Raised to Neutral From Underperform by BofA
- Siltronic Target Raised to EUR84.00 From EUR33.00 by BofA
- GODADDY INC <GDDY.N>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- BRISTOL-MYERS SQUIBB CO <BMY.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $73.00 FROM $67.00
- MARKETAXESS HOLDINGS INC <MKTX.O>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- Inficon Holding Raised to Neutral From Underperform by BofA
- Moderna Sees End-2026 Cash Balance $4.7B-$5.2B >MRNA
- MASTERCARD <MA.N>: JP MORGAN RAISES TARGET PRICE TO $720 FROM $655
- KARYOPHARM THERAPEUTICS INC <KPTI.O>: RBC CUTS TARGET PRICE TO $8 FROM $16
- Moderna 2Q Loss $782M >MRNA
- Cameco 2Q Profit Slides, Revenue Down
- Moderna: mRNA-1403 Phase Study Ongoing, Remains Blinded as Company Works Toward Enrolling Additional Cohort >MRNA
- FLOOR & DECOR HOLDINGS INC <FND.N>: TELSEY ADVISORY GROUP RAISES TARGET PRICE TO $68 FROM $61
- Besra Gold says Gladioli Group accepts conditional renewal offer for Jugan mining lease at Bau project
- Shoprite opens Checkers Hyper in Centurion, adds 115 jobs
- Foraco Q2 FY26 net profit drops 33.4% to US$4.01 million; revenue rises 22.4% to US$84.5 million
- Couche-Tard agrees to buy Żabka in PLN 32.62 billion deal backed by Partners Group, CVC
- Bitzero plans to prepay US$22.38 million senior secured loan by Aug. 6
- TransAlta Q2 FY26 net earnings swing to profit of $35 million; revenue rises 12.47% to $487 million
- Enbridge Still Sees 2026 Distributable Cash Flow C$5.70-C$6.10/Share >ENB
- Enbridge Still Sees 2026 Adjusted Ebitda C$20.2B-C$20.8B >ENB
- Werewolf Therapeutics: As of June 30, Cash and Cash Equivalents Were $22M >HOWL
- Enbridge 2Q Cash Provided by Operating Activities C$4.1B, Distributable Cash Flow C$2.9B >ENB
- Enbridge Reaffirms 2026 Guidance, Grows Secured Backlog to C$41B >ENB
- Enbridge 2Q Adjusted Ebitda C$4.8B >ENB
- AMAZON : DEUTSCHE BANK RAISES TARGET PRICE TO $325 FROM $315
- NEUROCRINE BIOSCIENCES, INC. <NBIX.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $190 FROM $170
- MARKETAXESS <MKTX.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $167 FROM $130
- INTERCONTINENTAL EXCHANGE <ICE.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $178 FROM $169
- RIVIAN <RIVN.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $24 FROM $23
- BAXTER INTERNATIONAL <BAX.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $27 FROM $20
- DEXCOM <DXCM.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $92 FROM $86
- HYATT HOTELS <H.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $205 FROM $210
- INTERNATIONAL PAPER <IP.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $50 FROM $39
- INTERNATIONAL PAPER <IP.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $50 FROM $39
- FTAI AVIATION LTD. <FTAI.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $290 FROM $315
- BUILDERS FIRSTSOURCE <BLDR.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $66 FROM $79
- ASHLAND : DEUTSCHE BANK RAISES TARGET PRICE TO $85 FROM $74
- YUM! BRANDS <YUM.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $174 FROM $177
- VICI PROPERTIES INC. <VICI.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $30 FROM $31
- HERSHEY <HSY.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $191 FROM $190
- Werewolf Therapeutics 2Q EPS 8c >HOWL
- Moderna 2Q-End Cash, Equivalents, Investments $6.9B >MRNA
- TransAlta 2Q EPS C$0.12 >TAC
- TransAlta 2Q Rev C$487M >TAC
- Moderna Reiterates Plan to Deliver Up to 10% Revenue Growth in 2026 >MRNA
- Moderna: mRNA-1403 Norovirus Vaccine Candidate Didn't Meet Statistical Criteria for Early Success at Phase 3 Interim Analysis >MRNA
- Enbridge 2Q EPS C$0.64 >ENB
- George Weston 2Q EPS C$0.34 >WN.T
- Dow Jones Top Financial Services Headlines at 7 AM ET: NatWest Raises Guidance and Brings Forward Share-Buyback Plans | Situational ...
- Enbridge 2Q Adj EPS C$0.63 >ENB
- Tenax Therapeutics 2Q Research and Development Expenses $12.9M >TENX
- Tenax Therapeutics 2Q Loss/Shr 35c >TENX
- Balchem 2Q EPS $1.39 >BCPC
- Balchem 2Q Net $44.6M >BCPC
- George Weston 2Q Adj EPS C$1.14 >WN.T
- Perella Weinberg Partners 2Q Adj EPS 20c >PWP
- Perella Weinberg Partners 2Q EPS 6c >PWP
- Perella Weinberg Partners 2Q Rev $156.5M >PWP
